DANIA BEACH, Fla.–(BUSINESS WIRE)–IntelePeer, the trusted leader in AI-powered automation and analytics for customer and patient interactions, today introduced at HLTH 2025 the SmartAnalytics™ Starter Pack. The Pack gives multi-site healthcare organi…
Yunqi Capital Issues Letter to STAAR Surgical’s Board Calling for Timely Convening of the Special Meeting to Vote on the Alcon Transaction
HONG KONG–(BUSINESS WIRE)–Yunqi Capital Limited (together with its affiliates and the funds it advises, “Yunqi Capital”), an investment management firm and 5.1% shareholder of STAAR Surgical Company (“STAAR” or the “Company”) (NASDAQ:STAA), today iss…
Uncategorized
Young ophthalmologists should not ignore ergonomics
ORLANDO — Younger ophthalmologists need to hear the message of proper ergonomics as early as possible, according to a speaker at the American Academy of Ophthalmology meeting.Robert Swan, MD, of SUNY Upstate Medical University, said that people usually…
Uncategorized
GLP-1s, fenofibrates reduce risk for diabetic macular edema
GLP-1 receptor agonists and fenofibrate medications significantly reduced the risk for developing diabetic macular edema, according to a study published in Ophthalmology Retina.Conversely, patients on calcium channel blockers were more likely to develo…
Uncategorized
FDA approves Yuflyma for two expanded indications
The FDA approved expanded indications of Yuflyma and its unbranded version to treat hidradenitis suppurativa in adolescents aged 12 years and older and uveitis in children aged 2 years and older, according to a press release.Yuflyma (adalimumab-aaty, C…
Uncategorized
FDA approves Epioxa for keratoconus
The FDA approved Epioxa for the treatment of keratoconus, Glaukos announced in a press release.“We’re proud to announce an extraordinary milestone for keratoconus patients with the approval of Epioxa,” Thomas Burns, Glaukos chairman and CEO, told Heali…